🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Melanoma Stage III

A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients NCT01638676Phase 1, Phase 21 site📍 Louisville University of Louisville · Tests: Vemurafenib, Metformin Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies NCT06508775NA7 sites📍 Berlin📍 Cologne📍 Erlangen Miltenyi Biomedicine GmbH · Tests: MB-CART19.1, MB-CART20.1, MB-CART2019.1 To Evaluate the Safety and Efficacy of ADP-TILIL7 in Patients With Locally Advanced or Metastatic Melanoma NCT06204991Phase 12 sites📍 Herlev📍 Herlev Inge Marie Svane · Tests: ADP-TILIL7, Cyclophosphamide, Fludarabine Phosphate, Proleukin Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study NCT07405086Phase 41 site📍 Portland OHSU Knight Cancer Institute · Tests: Biospecimen Collection, Immune Checkpoint Inhibitor Anti PD-1 Plus Postbiotic Versus Anti PD-1 Alone in Locally Advanced or Metastatic, Treatment naïve, Cutaneous Melanoma Study NCT07050940NA5 sites📍 Bari📍 Torino📍 Bari Azienda Ospedaliera di Perugia · Tests: Postbiotic, AntiPD1 Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma NCT07068074Phase 3181 sites📍 Birmingham📍 Daphne📍 Fairhope ECOG-ACRIN Cancer Research Group · Tests: Adjuvant Therapy, Comprehensive Geriatric Assessment, Computed Tomography, Positron Emission Tomography, Questionnaire … Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors NCT04771520Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Avapritinib Adjuvant Melatonin for Uveal Melanoma NCT05502900Phase 31 site📍 Stockholm Gustav Stalhammar · Tests: Melatonin Beta Glucan's Effect on Pembrolizumab Immunologic Response in Stage III-IV Melanoma NCT04513028NA1 site📍 Louisville Kelly McMasters · Tests: Beta-Glucan Neoadjuvant Combination Immunotherapy for Stage III Melanoma NCT03842943Phase 21 site📍 Louisville University of Louisville · Tests: Pembrolizumab, Talimogene Laherparepvec IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors NCT05039801Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Bevacizumab, Glutaminase-1 Inhibitor IACS-6274, Paclitaxel, Capivasertib Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma. NCT05727904Phase 382 sites📍 Birmingham📍 Duarte📍 Los Angeles Iovance Biotherapeutics, Inc. · Tests: Lifileucel plus Pembrolizumab, Pembrolizumab with Optional Crossover Period Pharmacokinetics, Safety, and Immunogenicity of Bmab1800 and Keytruda® as Adjuvant Monotherapy in Patients With Melanoma NCT07581509Phase 11 site📍 Barretos Biocon Biologics UK PLC · Tests: Bmab1800, US-Licensed Keytruda Adjuvant Tebentafusp in High Risk Ocular Melanoma NCT06246149Phase 315 sites📍 Lake Success📍 Brussels📍 Nice European Organisation for Research and Treatment of Cancer … · Tests: Tebentafusp Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary NCT02828202n/a27 sites📍 Amiens📍 Annecy📍 Besançon Assistance Publique - Hôpitaux de Paris · Tests: Biological, Tissular, Quality of life SWE-NEO: Swedish NeoAdjuvant Trial Comparing Monotherapy to Combined Immunotherapy in Resectable Stage III Melanoma NCT06794775Phase 33 sites📍 Gothenburg📍 Lund📍 Stockholm Hildur Helgadottir · Tests: Nivolumab, Nivolumab + Ipilimumab Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous Melanoma NCT07148245n/a1 site📍 San Francisco University of California, San Francisco · Tests: Blood Sample, Health Related Quality of Life Questionnaires (HRQoL), Medical Chart Review Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma NCT07475572Phase 11 site📍 Kiev Alvotech Swiss AG · Tests: AVT32-DRL_PB, Keytruda Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma NCT06295159Phase 21 site📍 Tampa H. Lee Moffitt Cancer Center and Research Institute · Tests: Nivolumab, Nivolumab + Relatlimab, Ipilimumab Neoadjuvant SHR-1210 Plus Apatinib for Resectable Stage III-IV Acral Melanoma NCT04331093Phase 21 site📍 Changchun Di Wu · Tests: SHR-1210+Apatinib FMT to Convert Response to Immunotherapy NCT05251389Phase 1, Phase 21 site📍 Amsterdam The Netherlands Cancer Institute · Tests: Fecal microbiota transplantation Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer NCT03819296Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Best Practice, Biospecimen Collection, Endoscopic Procedure, Fecal Microbiota Transplantation, Infliximab The Efficacy and Safety of PRTX007-003 Combined With Pembrolizumab in Resectable Stage III Melanoma NCT07565285Phase 27 sites📍 Waratah📍 Cairns📍 Greenslopes Primmune Therapeutics, Inc. · Tests: PRTX007, Pembrolizumab Exploratory Study With Parallel Controls on the Safety and Efficacy of Neoadjuvant Low Branched-Chain Amino Acid Diet in Combination With Anti-PD-1 Monoclonal Antibody for Stage III Melanoma NCT07586891NA1 site📍 Xi'an Xijing Hospital · Tests: Low Branched-Chain Amino Acid Diet Metronomic Cyclophosphamide With Pembrolizumab in Checkpoint Inhibitor Refractory Melanoma NCT06771544Phase 21 site📍 Orange University of California, Irvine · Tests: Pembrolizumab, Cyclophosphamide Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors NCT03755739Phase 2, Phase 31 site📍 Guanzhou Second Affiliated Hospital of Guangzhou Medical University · Tests: Checkpoint inhibitor (CPI) such as Pembrolizumab plus chemotherapy Excision of Lymph Node Trial (EXCILYNT) (Mel69) NCT05839912NA7 sites📍 Atlanta📍 Baltimore📍 Ann Arbor Craig L Slingluff, Jr · Tests: Excision of clinically detected lymph node metastasis before any systemic therapy, Excision of clinically detected lymp… The Multicentre Selective Lymphadenectomy Trial - 3 NCT07049276NA8 sites📍 Los Angeles📍 Newcastle📍 Wollstonecraft Melanoma Institute Australia · Tests: Index lymph node resection, Therapeutic lymph node dissection A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors NCT05970497Phase 1, Phase 215 sites📍 Los Angeles📍 Rancho Santa Margarita📍 Weston Krystal Biotech, Inc. · Tests: KB707, Opdualag, KEYTRUDA ®( Pembrolizumab) Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients NCT06199713n/a1 site📍 Madison University of Wisconsin, Madison · Tests: 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy